Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bimiralisib (1 trial)
pqr309 (8 trials)
Breast Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Lymphoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Trials (9 total)
Trial APIs (2 total)